Your browser doesn't support javascript.
loading
A targeted salvage therapy with Brentuximab vedotin in heavily treated refractory or relapsed pediatric Hodgkin lymphoma patients before and after stem cell transplantation.
Taçyildiz, Nurdan; Tanyildiz, Hikmet Gülsah; Ünal, Emel; Dinçaslan, Handan; Asarcikli, Fikret; Aksoy, Basak Adakli; Vatansever, Göksel; Yavuz, Gülsan.
Affiliation
  • Taçyildiz N; Divisions of Pediatric Oncology, Ankara University Faculty of Medicine, Ankara, Turkey.
  • Tanyildiz HG; Divisions of Pediatric Oncology, Ankara University Faculty of Medicine, Ankara, Turkey.
  • Ünal E; Divisions of Pediatric Oncology, Ankara University Faculty of Medicine, Ankara, Turkey.
  • Dinçaslan H; Divisions of Pediatric Oncology, Ankara University Faculty of Medicine, Ankara, Turkey.
  • Asarcikli F; Divisions of Pediatric Oncology, Ankara University Faculty of Medicine, Ankara, Turkey.
  • Aksoy BA; Divisions of Pediatric Oncology, Ankara University Faculty of Medicine, Ankara, Turkey.
  • Vatansever G; Department of Pediatrics, Ankara University Faculty of Medicine, Ankara, Turkey.
  • Yavuz G; Divisions of Pediatric Oncology, Ankara University Faculty of Medicine, Ankara, Turkey.
Turk J Pediatr ; 61(5): 671-676, 2019.
Article de En | MEDLINE | ID: mdl-32104998

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladie de Hodgkin / Thérapie de rattrapage / Transplantation de cellules souches hématopoïétiques / Antinéoplasiques immunologiques / Brentuximab védotine Type d'étude: Evaluation_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adolescent / Child / Female / Humans / Male Langue: En Journal: Turk J Pediatr Année: 2019 Type de document: Article Pays d'affiliation: Turquie Pays de publication: Turquie

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladie de Hodgkin / Thérapie de rattrapage / Transplantation de cellules souches hématopoïétiques / Antinéoplasiques immunologiques / Brentuximab védotine Type d'étude: Evaluation_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adolescent / Child / Female / Humans / Male Langue: En Journal: Turk J Pediatr Année: 2019 Type de document: Article Pays d'affiliation: Turquie Pays de publication: Turquie